About Gamma Vaccines
Gamma Vaccines is a Healthcare company based in Canberra (Australia) founded in 2009. Broad-spectrum intranasal vaccines against influenza viruses are developed in Australia. Gamma Vaccines has raised $551.69 thousand across 1 funding round from investors including SOHO Global Health. Gamma Vaccines offers products and services including Broad Spectrum Vaccines and NDV Vaccine. Its focus areas include HealthTech, Veterinary HealthTech, Biopharmaceuticals and Companion Animals. Its legal entity is Gamma Vaccines Ltd.
Company details
Gamma Vaccines was founded in 2009 in Canberra, Australia, within the biotechnology sector. Focus is placed on developing broad-spectrum, intranasal vaccines targeting human and avian influenza viruses. Inactivated virus strains are prepared using gamma irradiation to maintain protein structures, enabling intranasal administration. Potential exists for stockpiling as a universal flu vaccine for pandemic response. Additional research is conducted on vaccines for avian influenza in poultry and bacterial pneumonia prevention.
- Headquarters Canberra, Australia
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website gammavaccines.com
- Social LinkedIn
- Legal Name Gamma Vaccines Ltd
- Total Equity Funding$551.69K (USD)
in 1 rounds
- Latest Funding Round$551.69K (USD), Seed
Dec 2009
- Investors
Products & Services of Gamma Vaccines
Gamma Vaccines offers a comprehensive portfolio of products and services, including Broad Spectrum Vaccines and NDV Vaccine.
Vaccines targeting various human and animal viruses for disease prevention.
Vaccine for Newcastle disease virus in animals and poultry.
Funding Insights of Gamma Vaccines
Gamma Vaccines has successfully raised a total of $551.69K through 1 strategic funding round. The most recent funding activity was a Seed round of $551.69 thousand completed in December 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $551,694
- Total Rounds 1
- Last Round Seed — $551,694
- First Round $551,694
(Dec 2009)
- Investors Count 1
All 1 funding rounds of Gamma Vaccines with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2009 | $551,694 | Seed | – | – |
1 investors in total: 1 institutional.
Investors in Gamma Vaccines
Gamma Vaccines has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include SOHO Global Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
SOHO Global Health is engaged in herbal-based medicine development. | 2006 | sohoglobalhealth.com | Jakarta, Indonesia |
Investor details for Gamma Vaccines
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Gamma Vaccines
2 dated milestones of Gamma Vaccines, from founding to its latest funding, stage changes and deals.
- Founded Gamma Vaccines is founded.
- Funding First funding round of $552K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Gamma Vaccines
Gamma Vaccines was founded in 2009.
Gamma Vaccines is headquartered in Canberra, Australia. It is registered at Canberra, Australian Capital Territory, Australia.
Gamma Vaccines is a funded company, having raised a total of $551.69K across 1 funding round to date. The company's 1st funding round was a Seed of $551.69K, raised on Dec 2009.
Gamma Vaccines was founded in 2009 in Canberra, Australia, within the biotechnology sector. Focus is placed on developing broad-spectrum, intranasal vaccines targeting human and avian influenza viruses. Inactivated virus strains are prepared using gamma irradiation to maintain protein structures, enabling intranasal administration. Potential exists for stockpiling as a universal flu vaccine for pandemic response. Additional research is conducted on vaccines for avian influenza in poultry and bacterial pneumonia prevention.
Gamma Vaccines offers Broad Spectrum Vaccines and NDV Vaccine.
Gamma Vaccines has 1 investor. Key investors include SOHO Global Health.
Gamma Vaccines operates through Gamma Vaccines Ltd.